NOVONESIS BNOVONESIS BNOVONESIS B

NOVONESIS B

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.58CHF
Revenue estimate
‪939.71 M‬CHF
Market capitalization
‪25.07 B‬CHF
‪376.87 M‬CHF
‪2.23 B‬CHF
‪349.68 M‬
Beta (1Y)
0.26

About NOVONESIS (NOVOZYMES) A/S B

CEO
Ester Baiget
Headquarters
Lyngby
Employees (FY)
‪6.76 K‬
ISIN
DK0060336014
FIGI
BBG006TLSNM3
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NZM2 is 50.381 CHF — it has decreased by 4.51% in the past 24 hours. Watch NOVONESIS B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange NOVONESIS B stocks are traded under the ticker NZM2.
NOVONESIS B is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
NZM2 stock is 4.72% volatile and has beta coefficient of 0.26. Track NOVONESIS B stock price on the chart and check out the list of the most volatile stocks — is NOVONESIS B there?
NZM2 earnings for the last quarter are 0.31 CHF per share, whereas the estimation was 0.40 CHF resulting in a −21.67% surprise. The estimated earnings for the next quarter are 0.51 CHF per share. See more details about NOVONESIS B earnings.
NOVONESIS B revenue for the last quarter amounts to ‪573.65 M‬ CHF despite the estimated figure of ‪575.65 M‬ CHF. In the next quarter revenue is expected to reach ‪965.92 M‬ CHF.
Yes, you can track NOVONESIS B financials in yearly and quarterly reports right on TradingView.
NZM2 stock has fallen by 4.51% compared to the previous week, the month change is a 4.51% fall, over the last year NOVONESIS B has showed a 4.35% increase.
NZM2 net income for the last quarter is ‪86.99 M‬ CHF, while the quarter before that showed ‪121.17 M‬ CHF of net income which accounts for −28.21% change. Track more NOVONESIS B financial stats to get the full picture.
Today NOVONESIS B has the market capitalization of ‪25.07 B‬, it has increased by 2.39% over the last week.
NOVONESIS B dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NZM2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS B stock right from TradingView charts — choose your broker and connect to your account.
NZM2 reached its all-time high on Dec 17, 2021 with the price of 72.864 CHF, and its all-time low was 39.686 CHF and was reached on Oct 30, 2023. View more price dynamics on NZM2 chart.
See other stocks reaching their highest and lowest prices.
As of May 5, 2024, the company has ‪6.76 K‬ employees. See our rating of the largest employees — is NOVONESIS B on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVONESIS B technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVONESIS B stock shows the sell signal. See more of NOVONESIS B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVONESIS B future price: according to them, NZM2 price has a max estimate of 65.45 CHF and a min estimate of 45.81 CHF. Watch NZM2 chart and read a more detailed NOVONESIS B stock forecast: see what analysts think of NOVONESIS B and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVONESIS B EBITDA is ‪727.07 M‬ CHF, and current EBITDA margin is 32.72%. See more stats in NOVONESIS B financial statements.